Neuroscience of Psychedelics Workshop - Part 2/4

Scientific research into the neuropharmacology of classic psychedelics focuses on mapping molecular structures to receptor binding affinity and efficacy. Molecular modeling and mutagenesis experiments help delineate how specific substances such as LSD or psilocybin interact with serotonin 2A receptors to produce their psychoactive effects. Detailed analysis of binding pockets, particularly regarding polar residues and the role of alkyl groups, indicates distinct binding profiles for different classes of psychedelics. Computational modeling and animal studies provide insights into the downstream physiological impact of these receptor interactions. Mapping neural circuits, such as projections from the raphe nuclei to the thalamus and prefrontal cortex, establishes connections between psychedelics and modified states of consciousness. Experimental data from rat behavior models demonstrates time-dependent pharmacology and the potential for these substances to act as potent modulators of neural processing, with therapeutic implications for conditions that involve altered signaling pathways.